Advertisement

Topics

Schering-Plough Company Profile

12:51 EST 21st November 2017 | BioPortfolio

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each day on becoming a champion for our stakeholders. During the past four years, Schering-Plough has been building a new kind of health care company. Throughout Schering-Plough, there’s a desire to build long-term relationships with our stakeholders based on mutual confidence. This is evident in many ways. Our scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and well-being of people around the world. Our sales professionals, marketing teams, colleagues working at our plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust. All of this takes hard work, sharp execution, integrity and transparency on the part of Schering-Plough’s colleagues. Our global team is working to sustain and expand innovative new treatments. We’re determined to do our part to increase access to better health care for all people. And, we are focused on becoming the best in three key strategic areas: people, products and processes. We’re beginning to see the results of our efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From our perspective as a health care company, that means helping people around the world live better and live longer.

Location

2000 Galloping Hill Road
Kenilworth
NJ
07033-0530
United States of America

Contact

Phone: (908) 298-4000


News Articles [16 Associated News Articles listed on BioPortfolio]

TerraGen, Schering-Plough Collaboration to Focus on Discovery of Anti-Infectives

TerraGen Discovery Inc. (Vancouver, BC, Canada) and Schering-Plough Research Institute (SPRI; Kenilworth, NJ) have established a second collaboration to discover novel anti-infective compounds...

Merck & Co.: Merging With Schering-Plough and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Pamela Demain, Executive Director, Corporate Licensing at Merck & Co. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, th...

Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma

  Life Sciences Jobs   ...

Researchers Get Atomic View of FPT Inhibitors in Action

Researchers at Schering-Plough Research Institute report what they say is the first atomic view showing how FPT inhibitors work...

PTV News: Nov 5, 2009

Top stories on November 5th, 2009: Merck complete Schering-Plough merger Novartis buys Chinese vaccine maker BioPad’s Joe Mosala Molete on South African biotech Pfizer on partnering: Doug Giordan...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

Melinta Therapeutics Appoints Dan Weschler CEO

Melinta Therapeutics announced that Dan Weschler will become the antibiotics developer’s new president and CEO after the New Haven, CT, company completes its merger with Chapel Hill, NC-based Cempra...

Melinta Therapeutics Appoints Dan Wechsler CEO

Melinta Therapeutics announced that Dan Wechsler will become the antibiotics developer’s new president and CEO after the New Haven, CT, company completes its merger with Chapel Hill, NC-based Cempra...

PubMed Articles [0 Results]

None

Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Aim: to observe the graft versus tumor effect of Pegylated Interferonα-2b in patients with hematological malignancies relapsed after allogeneic hematopoietic stem cell transplantation (al...

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Bioequivalence study comparing test Acotral® ezetimibe 10 mg tablet manufactured by Laboratorios Phoenix, with a reference comparator Zetia® ezetimibe 10 mg tablet of Merck/Schering-Plou...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Companies [39 Associated Companies listed on BioPortfolio]

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering-Plough

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each ...

Schering-Plough Corporation

Schering-Plough HealthCare Products, Inc.

More Information about "Schering-Plough" on BioPortfolio

We have published hundreds of Schering-Plough news stories on BioPortfolio along with dozens of Schering-Plough Clinical Trials and PubMed Articles about Schering-Plough for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering-Plough Companies in our database. You can also find out about relevant Schering-Plough Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record